8 min read
April Fellow's Spotlight on Dr. Vivien Maltez
Our April Fellow's Spotlight goes to Dr. Vivien Maltez, PhD, an Assistant Professor in the Division of Allergy,...
Dr. Whitson received his B.S. in Biology at California State University Chico. In his Ph.D. studies at the University of Colorado Denver, he identified anti-tumor signaling events occurring downstream of vitamin D. His work discovered that the TGFβ family protein, GDF-15, suppresses angiogenesis by inhibiting the pro-angiogenic role of connective tissue growth factor. He received several awards including the Colorado Clinical and Translational Sciences Fellowship. His postdoctoral work at Stanford University uncovered resistance mechanisms involved in tumor resistance in skin cancer. He identified a role for serum response factor and myocardin-related transcription factors in tumor resistance and initiated a drug development effort to target these factors. As an investigator at the Genomics Institute of the Novartis Research Foundation, Dr. Whitson is involved in efforts to characterize transcription factor complexes to identify entry points for drug discovery. Current efforts employ functional genomics, proteomics and structural biology to gain a better understanding of oncogenic transcription factor complexes.
Research Area(s):
CancerResearch Keywords:
Mentor: Robert J. Deans, PhD
Apr 23, 2025 by Shannon Weiman
Our April Fellow's Spotlight goes to Dr. Vivien Maltez, PhD, an Assistant Professor in the Division of Allergy,...
Apr 22, 2025 by Shannon Weiman
Keystone Symposia was founded on the idea of bringing academic and industry scientists together to accelerate...